跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 7,727 条关于
“PSC Partners”
全部
7,727
临床试验
2,346
药物
705
机构
165
资讯
4,511
去年
VCU Joins Global Initiative to Accelerate Drug Development for Primary Sclerosing Cholangitis
去年
Mirum Pharmaceuticals Completes Enrollment in Phase 2b VISTAS Study for Primary Sclerosing Cholangitis Treatment
去年
Vancomycin Shows Promise in Treating PSC-Associated Inflammatory Bowel Disease
去年
FDA Aligns with Chemomab on Single Phase 3 Trial Path for Novel PSC Treatment Nebokitug
10个月前
Chemomab's Nebokitug Shows Sustained Anti-Inflammatory Effects in 48-Week PSC Extension Study
11个月前
Esperion Advances ESP-2001 for Primary Sclerosing Cholangitis, Targeting $1 Billion Market Opportunity
去年
Chemomab Announces Positive CM-101 Phase 2 Trial Results and Outlines Phase 3 Plans for Primary Sclerosing Cholangitis
6个月前
Chemomab Secures FDA Alignment for Phase 3 Trial of Nebokitug in Primary Sclerosing Cholangitis
8个月前
Monoclonal Antibody Nebokitug Shows Promise for Rare Liver Disease Primary Sclerosing Cholangitis
去年
Breakthrough in Primary Sclerosing Cholangitis: Dr. Falk Pharma's Norucholic Acid Shows Positive Phase 3 Results
第 1 页,共 452 页
上一页
下一页